Guerra Pan Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$638K Hold
11,962
0.39% 58
2025
Q4
$743K Hold
11,962
0.44% 49
2025
Q3
$719K Hold
11,962
0.43% 50
2025
Q2
$749K Hold
11,962
0.49% 47
2025
Q1
$720K Sell
11,962
-255
-2% -$15.8K 0.56% 48
2024
Q4
$713K Sell
12,217
-1,179
-9% -$70.1K 0.52% 49
2024
Q3
$793K Hold
13,396
0.63% 44
2024
Q2
$751K Buy
13,396
+21
+0.2% +$1.18K 0.63% 44
2024
Q1
$784K Buy
13,375
+114
+0.9% +$6.44K 0.72% 39
2023
Q4
$716K Sell
13,261
-585
-4% -$28.6K 0.68% 46
2023
Q3
$672K Hold
13,846
0.78% 43
2023
Q2
$782K Hold
13,846
0.87% 37
2023
Q1
$747K Hold
13,846
0.94% 34
2022
Q4
$728K Hold
13,846
0.99% 34
2022
Q3
$672K Sell
13,846
-50
-0.4% -$2.59K 0.98% 35
2022
Q2
$747K Hold
13,896
0.93% 37
2022
Q1
$772K Hold
13,896
0.93% 36
2021
Q4
$915K Buy
+13,896
New +$890K 0.91% 32

Other funds holding IHI

Guerra Pan Advisors's IHI Position: Q1 2026 in Review

Guerra Pan Advisors held its iShares US Medical Devices ETF (IHI) position steady in Q1 2026 at 11,962 shares worth $638K. The position accounts for 0.39% of the portfolio, ranked #58.

Guerra Pan Advisors first reported a position in IHI in Q4 2021 and has held it in 18 quarters since. The position peaked at $915K in Q4 2021. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Guerra Pan Advisors held 11,962 shares of iShares US Medical Devices ETF worth $638K as of Q1 2026.
  • Guerra Pan Advisors left its iShares US Medical Devices ETF share count unchanged in Q1 2026.
  • iShares US Medical Devices ETF made up 0.39% of Guerra Pan Advisors's portfolio in Q1 2026, its #58 holding.
  • Guerra Pan Advisors first reported a position in iShares US Medical Devices ETF in Q4 2021 and has held it in 18 quarters since.
  • Guerra Pan Advisors's iShares US Medical Devices ETF position peaked at $915K in Q4 2021.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Guerra Pan Advisors's 13F filing for Q1 2026, filed 12 May 2026.